1. At a Glance – Chemical Company or Financial Thriller?
Yasho Industries is that one student in class who suddenly tops one exam after failing three semesters — and now everyone is confused whether to clap or investigate. The company is sitting at a market cap of ₹1,652 crore, trading at ₹1,370, with a spicy P/E of 91.6, while ROE is chilling at a disappointing 1.63%.
Latest quarter? Oh, that’s where the drama is.
Revenue jumped 35% YoY and profit exploded 649% YoY — sounds like a multibagger trailer. But zoom out, and you’ll notice profit over the last 3 years has actually fallen by ~52%.
So what’s happening here?
- Short-term: Hero entry
- Long-term: Still in recovery mode
- Balance sheet: Slightly stressed
- Valuation: Premium without permission
And the biggest plot twist?
Despite all the growth talk, the company is still battling low utilization, high debt, and global chemical slowdown.
So the real question is —
Is this a turnaround story or just a temporary chemical reaction?
2. Introduction – From Chemical Lab to Stock Market Circus
Let’s set the scene.
You’re running a specialty chemical company. Demand is weak globally. China is dumping products like it’s Diwali sale. US tariffs mess up your exports. And your new plant is running at half capacity.
What do you do?
If you’re Yasho Industries — you build inventory, expand globally, sign long-term contracts, and hope the market wakes up before your working capital collapses.
Welcome to the chaos.
The company has:
- 148 products
- Presence in 50+ countries
- 2,000+ customers
- 65% revenue from exports
Sounds impressive, right?
But behind the curtain:
- Inventory days ~170
- Working capital cycle ~200 days
- Interest coverage barely above survival mode
That’s not a business. That’s a cash flow hostage situation.
And yet — management is confidently talking about ₹1,500 crore revenue potential by FY28.
Ambition?
